Table 3.
Clinical trials of new oral anticoagulants and aspirin for extended treatment of venous thromboembolism.
BID indicates twice daily; INR, international normalized ratio; and CRNM, clinically relevant nonmajor.
*Incidence per patient-year.
Clinical trials of new oral anticoagulants and aspirin for extended treatment of venous thromboembolism.
BID indicates twice daily; INR, international normalized ratio; and CRNM, clinically relevant nonmajor.
*Incidence per patient-year.
